How a pioneering software system is transforming brain surgery
A pioneering new approach being trialled at University College London Hospital (UCLH) hopes to make epilepsy surgery safer and easier. A team of researchers, clinicians and engineers from Epilepsy Society, UCLH, UCL and King’s College London have developed a world-leading software system called EpiNav, which stands for epilepsy navigation, and their work is being featured on today’s episode (10 October 2018) of the BBC’s Trust Me I’m a Doctor.
Review into sodium valproate - your chance to have your say
An independent safety review into the epilepsy medication, sodium valproate, is now officially open and has put out a 'call for evidence' from those affected by the drug.
Teva UK discontinues lamotrigine tablets
Teva UK have announced that they are discontinuing the following versions of Teva lamotrigine, although some will still be available for a limited period next year, as shown below:
Epilepsy Society-based neuropsychologist Sallie Baxendale wins international award
Neuropsychologist Sallie Baxendale, based at Epilepsy Society, has scooped a prestigious international award for the significant difference she has made to the treatment and care of people with epilepsy.
GP practice could close after failure to warn women of risks around sodium valproate
A GP practice in London could be closed down after inspectors found that staff had failed to warn women of the risks around the epilepsy medication sodium valproate during pregnancy.
Record fines for drug companies who overcharged NHS for anti-epilepsy drug
Pfizer was fined a record £84.2m by the Competition and Markets Authority (CMA) for increasing the price of its phenytoin sodium capsules by between 2,300-2,600 per cent over night in 2012. The CMA also fined distributor Flynn Pharma £5.2 million after it accused the pair of "excessive and unfair" pricing for the vital medicine used by around 48,000 patients in the UK.